text: SEC. 1. SHORT TITLE; TABLE OF CONTENTS.
  
      (a) Short Title.--This Act may be cited as the ``Comprehensive 
  Fentanyl Control Act''.
      (b) Table of Contents.--The table of contents of this Act is as 
  follows:
  
  Sec. 1. Short title; table of contents.
  Sec. 2. Findings; sense of Congress.
  Sec. 3. Controlled substance analogues.
  Sec. 4. Treatment of controlled substance analogues.
  Sec. 5. Enhanced penalties.
  Sec. 6. Endangering human life while illegally manufacturing controlled 
                              substance.
  Sec. 7. Temporary scheduling of synthetic opioid analgesics.
  Sec. 8. Tableting machines, encapsulating machines, and controlled 
                              substance counterfeiting materials.
  
  SEC. 2. FINDINGS; SENSE OF CONGRESS.
  
      (a) Findings.--The Congress finds as follows:
              (1) Fentanyl is a dangerous, synthetic opioid that's 50 to 
          100 times more potent than heroin and morphine and lethal in 
          doses as small as approximately 2 milligrams. Current 
          sentencing enhancements do not reflect the danger fentanyl 
          poses at lower quantities compared to other illicit substances.
              (2) Because a lethal dose of fentanyl can be accidentally 
          inhaled or absorbed through the skin, it's not just deadly to 
          its users, but it also threatens the lives of law enforcement 
          and customs officials, public health workers, first responders 
          and postal workers who risk unknowingly coming into contact 
          with fentanyl in its different forms.
              (3) From 2013 to 2014, the number of drug seizures by law 
          enforcement that tested positive for fentanyl increased by 426 
          percent and synthetic opioid-related deaths increased by 79 
          percent, with over 700 overdose deaths related to fentanyl. 
          However, due to variations in States' medical examiner and 
          coroner testing and reporting techniques, and deaths attributed 
          to heroin, this figure is believed to be significantly higher.
              (4) Illicitly manufactured fentanyl, pill press machines, 
          and other supplies needed to manufacture counterfeit pills 
          containing fentanyl are primarily sourced from China and widely 
          available for purchase on the Internet. Traffickers can 
          typically purchase a kilogram of fentanyl powder for as little 
          as $2,000 from a Chinese supplier, transform it into hundreds 
          of thousands of pills, and sell the counterfeit pills for 
          millions of dollars in profit.
              (5) In 2015, the Drug Enforcement Administration (DEA) and 
          Centers for Disease Control and Prevention (CDC) issued 
          nationwide alerts identifying fentanyl as a threat to public 
          health and safety and stating that the rise of counterfeit 
          pills that contain fentanyl in the illicit drug market will 
          likely result in more opioid-dependent individuals, overdoses, 
          and deaths.
              (6) The DEA has identified two key challenges for using the 
          Controlled Substances Analogue Enforcement Act of 1986 (21 
          U.S.C. 801 note) to prosecute individuals for violations 
          relating to fentanyl:
                      (A) The law requires that the substance have a 
                  substantially similar chemical structure to a 
                  controlled substance in order to be considered an 
                  analogue, yet the threshold for ``substantially 
                  similar'' has been cited by numerous courts as 
                  difficult to apply.
                      (B) Each case requires additional investigation to 
                  determine whether the substance in question was 
                  ``intended for human consumption'' and can therefore be 
                  considered an analogue.
              (7) Illicit fentanyl manufacturers are continuously 
          manipulating the chemical structures of the analogues in order 
          to stay ahead of researchers and law enforcement, thus making 
          prosecuting these crimes overly onerous. Furthermore, the speed 
          at which these alterations can be made outpace the current 
          authorities of the Department of Justice to schedule new 
          compounds and analogues under the Controlled Substances Act (21 
          U.S.C. 801 et seq.).
      (b) Sense of Congress.--It is the sense of the Congress that--
              (1) the trafficking in fentanyl and other synthetic opioids 
          represents a public health emergency in the United States and 
          requires a comprehensive legislative response;
              (2) the United States Government should use all available 
          measures to reduce the availability of illicit fentanyl, its 
          chemical precursors, and the equipment by which fentanyl may be 
          milled into counterfeit prescription pills;
              (3) the United States Government should make grants 
          available for State and local medical examiners and coroners to 
          screen for fentanyl in suspected opioid overdose cases in 
          regions reporting increases in fentanyl seizures, fentanyl-
          related overdose fatalities, or unusually high spikes in heroin 
          or unspecified drug overdose fatalities;
              (4) State and local law enforcement should, if safe and 
          possible, prioritize and expedite testing of drug samples taken 
          from drug overdose scenes and share the data on fentanyl drug 
          seizures with local health departments, coroners, and medical 
          examiners;
              (5) grants made available to address the opioid epidemic 
          should be used to improve States' surveillance of fentanyl-
          related deaths and to expand access to naloxone for first 
          responders, law enforcement, and health care personnel given 
          that multiple doses of naloxone must be administered per 
          overdose event; and
              (6) the United States Government, including the Secretary 
          of State, the Attorney General, the Secretary of Homeland 
          Security, and the Director of the Office of National Drug 
          Control Policy, should use the broad diplomatic and law 
          enforcement resources of the United States, in partnership with 
          the Governments of Mexico and China, to stop the trafficking of 
          illicit fentanyl into the United States.
  
  SEC. 3. CONTROLLED SUBSTANCE ANALOGUES.
  
      (a) In General.--Clauses (i), (ii), and (iii) of section 102(32)(A) 
  of the Controlled Substances Act (21 U.S.C. 802(32)(A)) are amended by 
  striking ``substantially'' each place it appears.
      (b) Rule of Construction.--Section 102(32)(A) of the Controlled 
  Substances Act (21 U.S.C. 82(32)(A)) shall not be construed to require 
  that a substance satisfy more than one of the clauses listed in such 
  section 102(32)(A) to meet the definition of a controlled substance 
  analogue.
  
  SEC. 4. TREATMENT OF CONTROLLED SUBSTANCE ANALOGUES.
  
      Section 203 of the Controlled Substances Act (21 U.S.C. 813) is 
  amended by striking ``shall, to the extent intended for human 
  consumption, be treated, for the purposes of any Federal law as a 
  controlled substance in schedule I'' and inserting ``shall, to the 
  extent to which it should be reasonably known to the manufacturer, 
  distributor, or dispenser that the controlled substance analogue is 
  intended for human consumption, be treated, with respect to such 
  manufacturer, distributor, or dispenser, respectively, for the purpose 
  of any Federal law as a controlled substance in schedule I''.
  
  SEC. 5. ENHANCED PENALTIES.
  
      (a) Controlled Substances Act Amendments.--The Controlled 
  Substances Act is amended--
              (1) in section 401(b)(1) (21 U.S.C. 841(b)(1))--
                      (A) in subparagraph (A)(vi)--
                              (i) by striking ``400 grams'' and inserting 
                          ``20 grams''; and
                              (ii) by striking ``100 grams'' and 
                          inserting ``5 grams''; and
                      (B) in subparagraph (B)(vi)--
                              (i) by striking ``40 grams'' and inserting 
                          ``2 grams''; and
                              (ii) by striking ``10 grams'' and inserting 
                          ``0.5 grams''; and
              (2) by adding at the end of section 401(b) (21 U.S.C. 
          841(b)) the following:
              ``(8) In the case of a violation of subsection (a), if the 
          mixture or substance contains a detectable amount of N-phenyl-
          [1-(2-phenylethyl)-4-piperidinyl] propanamide or any analogue 
          of N-phenyl-[1-(2-phenylethyl)-4-piperidinyl] propanamide and 
          also contains a detectable amount of another controlled 
          substance, then a court shall--
                      ``(A) not impose a term of probation;
                      ``(B) in addition to the term of punishment for the 
                  violation of this section, impose a term of 
                  imprisonment not to exceed 5 years; and
                      ``(C) no term of imprisonment imposed on a person 
                  under subparagraph (B) shall run concurrently with any 
                  term of imprisonment imposed on the person under any 
                  other provision of law.
              ``(9) In the case of a violation of subsection (a), if the 
          mixture or substance containing a detectable amount of N-
          phenyl-[1-(2-phenylethyl)-4-piperidinyl] propanamide or any 
          analogue of N-phenyl-[1-(2-phenylethyl)-4-piperidinyl] 
          propanamide was represented to be or sold as another controlled 
          substance, then a court shall--
                      ``(A) not impose a term of probation;
                      ``(B) in addition to the term of punishment for the 
                  violation of this section, impose a term of 
                  imprisonment not to exceed 5 years; and
                      ``(C) no term of imprisonment imposed on a person 
                  under subparagraph (B) shall run concurrently with any 
                  term of imprisonment imposed on the person under any 
                  other provision of law.''.
      (b) Controlled Substances Import and Export Act Amendments.--
  Section 1010(b) of the Controlled Substances Import and Export Act (21 
  U.S.C. 960(b)) is amended by adding at the end the following:
              ``(8) In the case of a violation of subsection (a), if the 
          mixture or substance containing a detectable amount of N-
          phenyl-[1-(2-phenylethyl)-4-piperidinyl] propanamide or any 
          analogue of N-phenyl-[1-(2-phenylethyl)-4-piperidinyl] 
          propanamide also contains a detectable amount of another 
          controlled substance, then a court shall--
                      ``(A) not impose a term of probation;
                      ``(B) in addition to the term of punishment for the 
                  violation of this section, impose a term of 
                  imprisonment not to exceed 5 years; and
                      ``(C) no term of imprisonment imposed on a person 
                  under subparagraph (B) shall run concurrently with any 
                  term of imprisonment imposed on the person under any 
                  other provision of law.
              ``(9) In the case of a violation of subsection (a), if the 
          mixture or substance containing a detectable amount of N-
          phenyl-[1-(2-phenylethyl)-4-piperidinyl] propanamide or any 
          analogue of N-phenyl-[1-(2-phenylethyl)-4-piperidinyl] 
          propanamide was represented to be or sold as another controlled 
          substance, then a court shall--
                      ``(A) not impose a term of probation;
                      ``(B) in addition to the term of punishment for the 
                  violation of this section, impose a term of 
                  imprisonment not to exceed 5 years; and
                      ``(C) no term of imprisonment imposed on a person 
                  under subparagraph (B) shall run concurrently with any 
                  term of imprisonment imposed on the person under any 
                  other provision of law.''.
  
  SEC. 6. ENDANGERING HUMAN LIFE WHILE ILLEGALLY MANUFACTURING CONTROLLED 
                SUBSTANCE.
  
      Section 417 of the Controlled Substances Act (21 U.S.C. 858) is 
  amended to read as follows:
  
  ``SEC. 417. ENDANGERING HUMAN LIFE WHILE ILLEGALLY MANUFACTURING 
                CONTROLLED SUBSTANCE.
  
      ``(a) In General.--Whoever, while manufacturing a controlled 
  substance in violation of this title, or attempting to do so, or 
  transporting or causing to be transported materials, including 
  chemicals, to do so, creates a substantial risk of harm to human life 
  shall be fined in accordance with title 18, United States Code, or 
  imprisoned not more than 10 years, or both.
      ``(b) Rebuttable Presumption.--For purposes of this section, there 
  shall be rebuttable presumption that any violation of subsection (a) 
  involving a detectable amount of N-phenyl-[1-(2-phenylethyl)-4-
  piperidinyl] propanamide, any analogue of N-phenyl-[1-(2-phenylethyl)-
  4-piperidinyl] propanamide, or the immediate precursor of such a 
  substance, creates a substantial risk of harm to human life.''.
  
  SEC. 7. TEMPORARY SCHEDULING OF SYNTHETIC OPIOID ANALGESICS.
  
      Section 201 of the Controlled Substances Act (21 U.S.C. 811) is 
  amended by adding at the end the following:
      ``(k) Temporary Scheduling of Synthetic Opioid Analgesics.--
              ``(1) Issuance of order.--The Attorney General may, by 
          order and without regard to the findings required by subsection 
          (a) of this section or section 202(b) and without regard to the 
          procedures prescribed by subsections (a) and (b) of this 
          section, place a substance in schedule I if--
                      ``(A) the substance is not listed in any other 
                  schedule in section 202;
                      ``(B) no exemption, approval, or licensing is in 
                  effect for the substance under section 505 of the 
                  Federal Food, Drug, and Cosmetic Act or section 351 of 
                  the Public Health Service Act; and
                      ``(C) the Attorney General has reason to believe 
                  that such substance--
                              ``(i) is a synthetic opioid analgesic;
                              ``(ii) is the object or intended object of 
                          clandestine importation, manufacture, or 
                          distribution; and
                              ``(iii) poses an imminent hazard to public 
                          health and safety.
              ``(2) Effective date of order.--An order issued under 
          paragraph (1) may not take effect until 5 days after its 
          publication in Federal Register.
              ``(3) Expiration of order.--An order issued under paragraph 
          (1) shall expire not later than 6 months after the date on 
          which it becomes effective, except that the Attorney General 
          may extend the order for up to 6 months.
              ``(4) Conclusion of rulemaking.--An order issued under 
          paragraph (1) with respect to a substance shall be vacated upon 
          the conclusion of a subsequent rulemaking proceeding initiated 
          under subsection (a) with respect to such substance.
              ``(5) Order not subject to judicial review.--An order 
          issued under paragraph (1) is not subject to judicial 
          review.''.
  
  SEC. 8. TABLETING MACHINES, ENCAPSULATING MACHINES, AND CONTROLLED 
                SUBSTANCE COUNTERFEITING MATERIALS.
  
      (a) Mailability.--
              (1) In general.--Chapter 30 of title 39, United States 
          Code, is amended by inserting after section 3002a, the 
          following new section:
  ``Sec. 3002b. Nonmailability of tableting machines, encapsulating 
                machines, and controlled substance counterfeiting 
                materials
      ``(a) Any tableting machine, encapsulating machine, or controlled 
  substance counterfeiting material is nonmailable matter, shall not be 
  carried or delivered by mail, and shall be disposed of as the Postal 
  Service directs, unless such device or material is mailed--
              ``(1) to a regulated person (as defined in section 102(38) 
          of the Controlled Substances Act); or
              ``(2) to a person registered to manufacture a controlled 
          substance by the Attorney General pursuant to section 302 of 
          the Controlled Substances Act.
      ``(b) For the purpose of this section--
              ``(1) the `controlled substance counterfeiting material' 
          means any punch, die, plate, stone, or other thing described 
          section 403(a)(5) of the Controlled Substances Act;
              ``(2) the term `encapsulating machine' means any manual, 
          semiautomatic, or fully automatic equipment which may be used 
          to fill shells or capsules with any powdered, granular, 
          semisolid, or liquid material; and
              ``(3) the term `tableting machine' means any manual, 
          semiautomatic, or fully automatic equipment which may be used 
          for the compaction or molding of powdered or granular solids, 
          or semisolid material, to produce coherent solid tablets.''.
              (2) Clerical amendment.--The table of sections for chapter 
          30 of title 39, United States Code, is amended by inserting 
          after the item relating to section 3002a the following new 
          item:
  
  ``3002b. Nonmailability of tableting machines, encapsulating machines, 
                              and controlled substance counterfeiting 
                              materials.''.
      (b) Penalty.--
              (1) In general.--Chapter 83 of title 18, United States 
          Code, is amended by inserting after section 1716E the following 
          new section:
  ``Sec. 1716F. Nonmailability of tableting machines, encapsulating 
                machines, and controlled substance counterfeiting 
                materials
      ``Whoever knowingly deposits for mailing or delivery, or knowingly 
  causes to be delivered by mail according to the direction thereon, or 
  at any place to which it is directed to be delivered by the person to 
  whom it is addressed, any matter declared to be nonmailable by section 
  3002c of title 39, shall be fined under this title or imprisoned not 
  more than 1 year, or both.''.
              (2) Clerical amendment.--The table of sections for chapter 
          83 of title 18, United States Code, is amended by inserting 
          after the item relating to section 1716E the following new 
          item:
  
  ``1716F. Nonmailability of tableting machines, encapsulating machines, 
                              and controlled substance counterfeiting 
                              materials.''.
target: Comprehensive Fentanyl Control Act This bill amends the Controlled Substances Act (CSA) to modify the definition of &quot;controlled substance analogue&quot; to mean a substance that has a similar (previously, substantially similar) chemical structure and pharmacological effect to a schedule I controlled substance.  Additionally, it modifies the treatment of controlled substance analogues. Under current law, a controlled substance analogue that is intended for human consumption is treated as a schedule I controlled substance. This bill replaces the "intended for human consumption" qualifier with a "not a chemical substance subject to the Toxic Substances Control Act" qualifier. Specifically, a controlled substance analogue that is not a chemical substance under the Toxic Substances Control Act is treated as a schedule I controlled substance.  The bill modifies the drug quantity thresholds that trigger a mandatory minimum prison term for a defendant who manufactures, distributes, or possesses with intent to distribute fentanyl.  It also establishes a consecutive mandatory prison term for a defendant who commits a drug offense involving a detectable amount of heroin or fentanyl.  The bill allows the Drug Enforcement Administration to temporarily place a substance into schedule I if it reasonably believes that the substance: (1) is a synthetic opioid analgesic; (2) is the object of clandestine importation, manufacture, or distribution; and (3) poses an imminent hazard to public health and safety. Finally, the bill makes it a crime to knowingly mail to an unauthorized person equipment that may be used to manufacture counterfeit controlled substances.
feat_title: Comprehensive Fentanyl Control Act